Stemline Therapeutics is a clinical-stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSC) as well as the tumor bulk. Among Stemline’s drug candidates are SL-401 and SL-701, both of which have demonstrated single agent clinical activity … Continue reading →

Mast Therapeutics is focused on developing therapies for patients with serious and life-threatening diseases. The biopharmaceutical company’s lead product candidate, MST-188, is designed to treat patients with sickle cell disease. The hemorheologic, cytoprotective and anti-inflammatory therapy is currently in phase … Continue reading →

ARCA biopharma is focused on developing genetically targeted therapies for cardiovascular diseases. Gencaro (bucindolol hydrochloride), the company’s lead product candidate, is an investigational, pharmacologically unique beta-blocker and mild vasodilator that is being developed for atrial fibrillation. The company has identified … Continue reading →

Agenus is a biotechnology company engaged in the development of treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, and it has multiple product candidates advancing through the clinic; this includes … Continue reading →

Oncothyreon develops therapeutics products to treat various forms of cancer. The biopharmaceutical company’s lead candidate is a vaccine used in the treatment of non-small cell lung cancer, but it also has products designed to treat B-cell lymphoma and other diseases. … Continue reading →

Advanced Cell Technology is a biotechnology company engaged in applying cellular technology in the field of regenerative medicine. The company applies stem cell-based technologies – both for adult and “embryo safe” human embryonic stem cells – and other proprietary regenerative … Continue reading →